Human Alzheimer’s disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Amino Acids

• Publication date

  2011-04-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00726-010-0645-9PMID 20563614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enrichment of O-GlcNAc modified proteins by the periodate oxidation-hydrazide resin capture approach.

  2010cited by this paper
• Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides

  2009cited by this paper
• Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

  2009cited by this paper
• An unstructured protein with destructive potential: TPPP/p25 in neurodegeneration

  2009cited by this paper
• In Vivo Modulation of O-GlcNAc Levels Regulates Hippocampal Synaptic Plasticity through Interplay with Phosphorylation*

  2009influential reference
• Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease.

  2009cited by this paper
• Proteasome subunit Rpn13 is a novel ubiquitin receptor

  2008cited by this paper
• Age-Dependent Neurodegeneration Accompanying Memory Loss in Transgenic Mice Defective in Mitochondrial Aldehyde Dehydrogenase 2 Activity

  2008cited by this paper
• The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.

  2008cited by this paper
• Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment

  2008cited by this paper
• A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.

  2008cited by this paper
• A quantitative atlas of mitotic phosphorylation

  2008cited by this paper
• The ubiquitin-proteasome system in Alzheimer's disease

  2008cited by this paper
• Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis

  2008cited by this paper
• Hybridization of pulsed-Q dissociation and collision-activated dissociation in linear ion trap mass spectrometer for iTRAQ quantitation.

  2008cited by this paper
• Investigating interactions mediated by the presynaptic protein bassoon in living cells by Foerster's resonance energy transfer and fluorescence lifetime imaging microscopy.

  2008cited by this paper
• Robust and Sensitive iTRAQ Quantification on an LTQ Orbitrap Mass Spectrometer*S

  2008cited by this paper
• Activities of the chaperonin containing TCP-1 (CCT): implications for cell cycle progression and cytoskeletal organisation.

  2008cited by this paper
• Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase.

  2008cited by this paper
• The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases

  2007cited by this paper
• iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer.

  2007influential reference
• Phosphorylation Blocks the Activity of Tubulin Polymerization-promoting Protein (TPPP)

  2007cited by this paper
• Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease.

  2007cited by this paper
• Vesicle pools and synapsins: New insights into old enigmas

  2007cited by this paper
• Identification of carbonylated proteins from enriched rat skeletal muscle mitochondria using affinity chromatography‐stable isotope labeling and tandem mass spectrometry

  2007influential reference
• Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: On defects in the cytochrome c oxidase complex and aldehyde detoxification

  2006cited by this paper
• Differential Effects of Mitochondrial Heat Shock Protein 60 and Related Molecular Chaperones to Prevent Intracellular β-Amyloid-induced Inhibition of Complex IV and Limit Apoptosis*

  2006cited by this paper
• Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1

  2006cited by this paper
• Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory.

  2006cited by this paper
• Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting

  2006cited by this paper
• ELKS, a protein structurally related to the active zone protein CAST, is involved in Ca2+‐dependent exocytosis from PC12 cells

  2006cited by this paper
• O-Linked N-Acetylglucosamine Proteomics of Postsynaptic Density Preparations Using Lectin Weak Affinity Chromatography and Mass Spectrometry*S

  2006cited by this paper
• Microtubule-associated Protein MAP1A, MAP1B, and MAP2 Proteolysis during Soluble Amyloid β-Peptide-induced Neuronal Apoptosis

  2006cited by this paper
• Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid β-(1–42) Aggregation in Vitro*

  2006cited by this paper
• High amplitude short time excitation: A method to form and detect low mass product ions in a quadrupole ion trap mass spectrometer

  2006cited by this paper
• Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3.

  2006cited by this paper
• What primary microcephaly can tell us about brain growth.

  2006cited by this paper
• Glucose metabolism and Alzheimer's disease.

  2005cited by this paper
• Alzheimer's disease: Aβ, tau and synaptic dysfunction

  2005cited by this paper
• Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease.

  2005cited by this paper
• Alzheimer's disease: Abeta, tau and synaptic dysfunction.

  2005cited by this paper
• p25α Stimulates α-Synuclein Aggregation and Is Co-localized with Aggregated α-Synuclein in α-Synucleinopathies*

  2005cited by this paper
• Proteomic Analysis of in Vivo Phosphorylated Synaptic Proteins*

  2005cited by this paper
• Mass spectrometry–based proteomics turns quantitative

  2005cited by this paper
• i-Tracker: For quantitative proteomics using iTRAQ™

  2005cited by this paper
• Molecular dissection of the photoreceptor ribbon synapse

  2005cited by this paper
• Protein O-GlcNAc Modulates Motility-associated Signaling Intermediates in Neutrophils*

  2005cited by this paper
• Amyloid‐β induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease

  2005cited by this paper
• Synaptic Changes in Alzheimer ’ s Disease Increased Amyloid-and Gliosis in Surviving Terminals Is Accompanied by Decreased PSD-95 Fluorescence

  2004cited by this paper
• O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

  2004cited by this paper
• Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S

  2004cited by this paper
• Mitogen-activated protein kinases in synaptic plasticity and memory.

  2004cited by this paper
• PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation

  2004cited by this paper
• Physical and functional interaction of the active zone proteins, CAST, RIM1, and Bassoon, in neurotransmitter release

  2004cited by this paper
• Mitochondrial ALDH2 Deficiency as an Oxidative Stress

  2004cited by this paper
• Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases*

  2004cited by this paper
• Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.

  2004cited by this paper
• Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

  2004cited by this paper
• Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons.

  2004cited by this paper
• Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

  2004cited by this paper
• Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

  2004cited by this paper
• CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

  2004cited by this paper
• Heat Shock Protein 70 Participates in the Neuroprotective Response to Intracellularly Expressed β-Amyloid in Neurons

  2004cited by this paper
• 26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster.

  2003cited by this paper
• O-GlcNAc modification is an endogenous inhibitor of the proteasome.

  2003cited by this paper
• Chaperones increase association of tau protein with microtubules

  2003cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• Synaptic plasticity in animal models of early Alzheimer's disease.

  2003cited by this paper
• Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms

  2003cited by this paper
• Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex.

  2003cited by this paper
• A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance

  2003cited by this paper
• Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

  2002cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Phosphorylation of MEK1 by cdk5/p35 Down-regulates the Mitogen-activated Protein Kinase Pathway*

  2002cited by this paper
• Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins

  2001cited by this paper
• Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II.

  2001cited by this paper
• Cytosolic O‐glycosylation is abundant in nerve terminals

  2001cited by this paper
• Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.

  2000cited by this paper
• Piccolo, a presynaptic zinc finger protein structurally related to bassoon.

  2000cited by this paper
• Impaired Proteasome Function in Alzheimer's Disease

  2000cited by this paper
• Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease

  1999cited by this paper
• The role of oxidative stress in Alzheimer disease.

  1999cited by this paper
• Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

  1999cited by this paper
• The N-terminal ERK-binding Site of MEK1 Is Required for Efficient Feedback Phosphorylation by ERK2 in Vitro and ERK Activation in Vivo *

  1999cited by this paper
• Identification of septins in neurofibrillary tangles in Alzheimer's disease.

  1998cited by this paper
• Immunocytochemical Co‐localization of the Proteasome in Ubiquitinated Structures in Neurodegenerative Diseases and the Elderly

  1997cited by this paper
• Dynamic Glycosylation of Nuclear and Cytosolic Proteins

  1997cited by this paper
• The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine*

  1996cited by this paper
• Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database.

  1995cited by this paper
• Growth factor‐stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1)

  1994cited by this paper
• Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities

  1980cited by this paper
• The Down syndrome.

  1980cited by this paper

• Neuroectoderm phenotypes in a human stem cell model of O-GlcNAc transferase associated with intellectual disability.

  2024cites this paper
• Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy

  2023cites this paper
• Deciphering the Properties and Functions of Glycoproteins Using Quantitative Proteomics

  2023cites this paper
• Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis

  2023cites this paper
• Growing and dividing: how O-GlcNAcylation leads the way

  2023cites this paper
• Neuroectoderm phenotypes in a human stem cell model of O-GlcNAc transferase intellectual disability

  2023cites this paper
• Hexosamine Biosynthetic Pathway and O-GlcNAc cycling of Glucose Metabolism in Brain Function and Disease.

  2023cites this paper
• Subcellular proteomics insights into Alzheimer's disease development

  2023cites this paper
• Demystifying the O-GlcNAc Code: A Systems View.

  2022cites this paper
• Recent development of analytical methods for disease-specific protein O-GlcNAcylation

  2022cites this paper
• An overview of tools to decipher O-GlcNAcylation from historical approaches to new insights.

  2022cites this paper
• SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy

  2022cites this paper
• Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease

  2021cites this paper
• A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer

  2021cites this paper
• Analytical and Biochemical Perspectives of Protein O-GlcNAcylation.

  2021cites this paper
• A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-based Glycoproteomics.

  2020cites this paper
• Evaluation of Glucosamine Effect Against Heart and Brain Damage Induced by Y-radiation or Aluminium Chloride in Female Rats

  2020cites this paper
• A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics

  2020cites this paper
• Global and site-specific analysis of protein glycosylation in complex biological systems with Mass Spectrometry.

  2019cites this paper
• Dual-Arm Nanocapsule Targets Neuropilin-1 Receptor and Microtubule: A Potential Nanomedicine Platform.

  2019cites this paper
• Chemical and Biochemical Strategies To Explore the Substrate Recognition of O‐GlcNAc‐Cycling Enzymes

  2018cites this paper
• Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.

  2018cites this paper
• Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's disease

  2017cites this paper
• Understanding Alzheimer's disease by global quantification of protein phosphorylation and sialylated N-linked glycosylation profiles: A chance for new biomarkers in neuroproteomics?

  2017cites this paper
• O-GlcNAcylation and neurodegeneration.

  2017cites this paper
• Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer’s disease

  2016cites this paper
• Alzheimer's disease: are blood and brain markers related? A systematic review

  2016cites this paper
• Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling

  2016cites this paper
• α-Cyclodextrin Interacts Close to Vinblastine Site of Tubulin and Delivers Curcumin Preferentially to the Tubulin Surface of Cancer Cell.

  2016cites this paper
• Identification of proteins that are differentially expressed in brains with Alzheimer's disease using iTRAQ labeling and tandem mass spectrometry.

  2016cites this paper
• Glycosylation patterns and PHA-E-associated glycoprotein profiling associated with early hepatic encephalopathy in Chinese hepatocellular carcinoma patients.

  2016influential citation
• Quantitation of protein post-translational modifications using isobaric tandem mass tags.

  2015cites this paper
• Explorative and targeted neuroproteomics in Alzheimer's disease.

  2015cites this paper
• Neuroproteomics — LC-MS Quantitative Approaches

  2015cites this paper
• Translational Study of Alzheimer's Disease (AD) Biomarkers from Brain Tissues in AβPP/PS1 Mice and Serum of AD Patients

  2015cites this paper
• The Emerging Link between O-GlcNAc and Alzheimer Disease*

  2014cites this paper
• Recent approaches for studying the role of glia.

  2014cites this paper
• Functional O-GlcNAc modifications: Implications in molecular regulation and pathophysiology

  2014influential citation
• Tandem lectin weak affinity chromatography for glycoprotein enrichment.

  2013cites this paper
• Tools for probing and perturbing O-GlcNAc in cells and in vivo.

  2013cites this paper
• Tubulin Polymerization Promoting Protein 1 (Tppp1) Phosphorylation by Rho-associated Coiled-coil Kinase (Rock) and Cyclin-dependent Kinase 1 (Cdk1) Inhibits Microtubule Dynamics to Increase Cell Proliferation*

  2013cites this paper
• Brain site-specific proteome changes in aging-related dementia

  2013cites this paper
• Mass Spectrometry of Glycoproteins

  2013cites this paper
• Recent advances in quantitative neuroproteomics.

  2013cites this paper
• Protein–Ligand Interaction Study of CpOGA in Complex with GlcNAcstatin

  2013cites this paper
• O-Linked β-N-Acetylglucosamine (O-GlcNAc) Site Thr-87 Regulates Synapsin I Localization to Synapses and Size of the Reserve Pool of Synaptic Vesicles*

  2013cites this paper
• Massenspektrometrische Identifizierung posttranslationaler Modifizierungen mit monomerem N-Acetylglukosamin an Proteasomen

  2012cites this paper
• AGE DEPENDENT ΒETA-AMYLOID ISOFORMS AND IMPLICATIONS OF DIFFERENT DRUG TREATMENTS AS STUDIED IN DIFFERENT TRANSGENIC MOUSE MODELS AND CELL LINES

  2012cites this paper
• An insight into iTRAQ: where do we stand now?

  2012cites this paper
• The use of biophysical proteomic techniques in advancing our understanding of diseases

  2012cites this paper
• Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.

  2012cites this paper
• Developmental Regulation of Protein O-GlcNAcylation, O-GlcNAc Transferase, and O-GlcNAcase in Mammalian Brain

  2012cites this paper
• The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

  2012cites this paper
• Protein quantitation using iTRAQ: Review on the sources of variations and analysis of nonrandom missingness.

  2012cites this paper
• Transforming Glycoscience: A Roadmap for the Future

  2012cites this paper
• Computational Analysis of Human OGA Structure in Complex with PUGNAc and NAG-Thiazoline Derivatives

  2012cites this paper
• Detection and Analysis of Proteins Modified by O‐Linked N‐Acetylglucosamine

  2011cites this paper
• Proteomic databases and tools to decipher post-translational modifications.

  2011cites this paper
• Lectin‐affinity chromatography brain glycoproteomics and Alzheimer disease: Insights into protein alterations consistent with the pathology and progression of this dementing disorder

  2011cites this paper
• Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.

  2011cites this paper
• Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1

  2011cites this paper
• Detection and Analysis of Proteins Modified by O‐Linked N‐Acetylglucosamine

  2011cites this paper